Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Cardiome Pharma Corporation Ordinary Shares (Canada) Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 4.58||$ 10.40|
|Low||$ 4.37||$ 3.70|
The current last sale of $4.47 is 20.81% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a specialty pharmaceutical company dedicated to the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. We strive to find innovative, differentiated medicines that provide therapeutic and economic value to patients, physicians and healthcare systems. We currently have two marketed, in-hospital cardiology products, BRINAVESSTM and AGGRASTAT®, which are commercially available in markets outside of the United States, and commercialization rights to marketed cardiology products, ESMOCARD® and ESMOCARD LYO® (esmolol hydrochloride), in certain European countries. We have also licensed commercialization rights to a drug/device combination product, TREVYENT®, for the treatment of pulmonary arterial hypertension ("PAH") in certain regions outside the United States. ... More ...
Where does CRME fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-1.34|
|Quarterly EPS Est:||-0.18|